Endothelium-independent relaxation to cannabinoids in rat-isolated mesenteric artery and role of Ca2+ influx

British Journal of Pharmacology

Volumn 139, Issue 3, 2003, Pages 585-597

  Vanessa Ho, W S ^a   Hiley, C Robin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aminoalkylindoles; Anandamide; Cannabinoid receptor antagonists; Cannabinoids; Ionomycin; JWH 015; Mesenteric artery (rat); SR 141716A

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID; CAPSAICIN; ENDOTHELIUM DERIVED RELAXING FACTOR; METHOXAMINE; RIMONABANT; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; ENANTIOMER; EXTRACELLULAR CALCIUM; IMMUNOREACTIVITY; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; MESENTERIC ARTERIES; RATS; RATS, WISTAR; VASODILATION;

EID: 0038339996     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705280     Document Type: Article

References (40)

1. CHAYTOR, A.T., MARTIN, P.E., EVANS, W.H., RANDALL, M.D. & GRIFFITH, T.M. (1999). The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J. Physiol., 520, 539 - 550.
2. CRIDDLE, D.N., DE MOURA, R.S., GREENWOOD, I.A. & LARGE, W.A. (1996). Effect of niflumic acid on noradrenaline-induced contractions of the rat aorta. Br. J. Pharmacol., 118, 1065 - 1071.
3. 1) receptor expression is associated with mesenteric resistance vessels but not thoracic aorta in the rat. Br. J. Pharmacol., 12, 95.
4. DE PETROCELLIS, L., BISOGNO, T., MACCARRONE, M., DAVIS, J.B., FINAZZI-AGRO, A. & DI MARZO, V. (2001). The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 276, 12856 - 12863.
5. DEUTSCH, D.G., GOLIGORSKY, M.S., SCHMID, P.C., KREBSBACH, R.J., SCHMID, H.H.O., DAS, S.K., DEY, S.K., ARREAZA, G., THORUP, C., STEFANO, G. & MOORE, L.C. (1997). Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest., 100, 1538 - 1546.
6. ELLIS, J. & SEIDENBERG, M. (2000). Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: studies with chimeric receptors. Mol. Pharmacol., 58, 1451 - 1460.
7. FELDER, C.C., VELUZ, J.S., WILLIAMS, H.L., BRILEY, E.M. & MASUDA, L.A. (1992). Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol., 42, 838 - 845.
8. 2+ channel current. Am. J. Physiol., 276, H2085-H2093.
9. 35S]thio)-triphosphate binding assay in rat cerebellar membranes. J. Pharmacol. Exp. Ther., 285, 553 - 560.
10. 2, a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. U.S.A., 25, 14228 - 14233.
11. HARRIS, D., MCCULLOCH, A.I., KENDALL, D.A. & RANDALL, M.D. (2002). Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J. Physiol., 539, 893 - 902.
12. HILLARD, C.J. (2000). Endocannabinoids and vascular function. J. Pharmacol. Exp. Ther., 294, 27 - 32.
13. HO, W.-S.V. & HILEY, C.R. (2003). Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br. J. Pharmacol. 138, 1320 - 1332.
14. o to the inhibition of adenylyl cyclase in carotid artery smooth muscle. Br. J. Pharmacol., 128, 59 - 64.
15. 2 receptors. Proc. Natl. Acad. Sci. U.S.A., 96, 14136 - 14141.
16. JOHNSON, D.E., HEALD, S.L., DALLY, R.D. & JANIS, R.A. (1993). Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding. Prostagland: Leukot. Essent. Fatty Acids, 48, 429 - 437.
17. KARAKI, H., OZAKI, H., HORI, M., MITSUSAITO, M., AMINO, K.I., HARADA, K.I., MIYAMOTO, S., NAKAZAWA, H., WON, K.J. & SATO, K. (1997). Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev., 49, 157 - 230.
18. 1-like cannabinoid receptors. J. Pharmacol. Exp. Ther., 281, 1030 - 1037.
19. LAN, R., LIU, Q., FAN, P., LIN, S., FERNANDO, S.R., MCCALLION, D., PERTWEE, R. & MAKRIYANNIS, A. (1999). Structure - activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J. Med. Chem., 42, 769 - 776.
20. LIU, C. & HERMANN, T.E. (1978). Characterization of ionomycin as a calcium ionophore. J. Biol. Chem., 253, 5892 - 5894.
21. 1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn Schmiedeberg's Arch. Pharmacol., 364, 562 - 569.
22. MAGGI, C.A. & MELI, A. (1988). The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen. Pharmacol., 19, 1 - 43.
23. MUKHOPADHYAY, S., CHAPNICK, B.M. & HOWLETT, A.C. (2002). Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am. J. Physiol., 282, H2046 - H2054.
24. MULVANY, M.L.J. & HALPERN, W. (1977). Contractile responses of small resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19 - 26.
25. 2 receptors. Pharmacol. Ther., 74, 129 - 180.
26. 1 cannabinoid receptor. Am. J. Physiol., 274, H375 - H381.
27. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284, 644 - 650.
28. ROSS, R.A., GIBSON, T.M., BROCKIE, H.C., LESLIE, M., PASHMI, G., CRAIB, S.J., DI MARZO, V. & PERTWEE, R.G. (2001). Structure - activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Br. J. Pharmacol., 132, 631 - 640.
29. SEGAL, A.S., HAYSLETT, J.P. & DESIR, G.V. (2002). On the natriuretic effect of verapamil: inhibition of ENaC and transepithelial sodium transport. Am. J. Physiol., 283, F765 - F770.
30. SHEN, M. & THAYER, S.A. (1998). The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res., 783, 77 - 84.
31. 2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 278, 989 - 999.
32. SLIPETZ, D.M., O'NEILL, G.P., FAVREAU, L., DUFRESNE, C., GALLANT, M., GAREAU, Y., GUAY, D., LABELLE, M. & METTERS, K.M. (1995). Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol. Pharmacol., 48, 352 - 361.
33. 1 receptors. Eur. J. Pharmacol., 423, 203 - 210.
34. WAGNER, J.A., VARGA, K., JÁRAI, Z. & KUNOS, G. (1999). Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension, 33, 429- 434.
35. WHITE, R. & HILEY, C.R. (1997). A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol., 122, 1573 - 1584.
36. WHITE, R. & HILEY, C.R. (1998a). The actions of some cannabinoid receptor ligands in rat isolated mesenteric artery. Br. J. Pharmacol., 125, 533 - 541.
37. WHITE, R. & HILEY, C.R. (1998b). The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery. Br. J. Pharmacol., 125, 689 - 696.
38. WHITE, R., HO, W.-S.V., BOTTRILL, F.E., FORD, W.R. & HILEY, C.R. (2001). Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol., 134, 921 - 929.
39. ZYGMUNT, P.M., HÖGESTÄTT, E.D., WALDECK, K., EDWARDS. G., KIRKUP, A.J. & WESTON, A.H. (1997). Studies on the effects of anandamide in rat hepatic artery. Br. J. Pharmacol., 122, 1679 - 1686.
40. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SØRGÅRD, M., DI MARZO, V., JULIUS, D. & HÖGESTÄTT, E.D. (1999). Vanilloid receptors on sensory nerves mediate vasodilator action of anandamide. Nature, 400, 452 - 457.